Vercellini Paolo
No ORCID on file
· 3 papers in corpus
other
2018
Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis. As the degree of ovarian suppression obtained with e…
2017
1994